FI105399B - Menetelmä terapeuttisesti käyttökelpoisten N-syano-3-pyridiinikarboksiamidiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten N-syano-3-pyridiinikarboksiamidiinijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI105399B
FI105399B FI943508A FI943508A FI105399B FI 105399 B FI105399 B FI 105399B FI 943508 A FI943508 A FI 943508A FI 943508 A FI943508 A FI 943508A FI 105399 B FI105399 B FI 105399B
Authority
FI
Finland
Prior art keywords
cyano
amino
chlorophenyl
compound
eller
Prior art date
Application number
FI943508A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943508A0 (fi
FI943508A (fi
Inventor
Tomoko Kashiwabara
Nobuyuki Ogawa
Tatsuo Nakajima
Hideki Okawara
Soichiro Kaneta
Original Assignee
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery filed Critical Kirin Brewery
Publication of FI943508A0 publication Critical patent/FI943508A0/fi
Publication of FI943508A publication Critical patent/FI943508A/fi
Application granted granted Critical
Publication of FI105399B publication Critical patent/FI105399B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI943508A 1992-01-28 1994-07-26 Menetelmä terapeuttisesti käyttökelpoisten N-syano-3-pyridiinikarboksiamidiinijohdannaisten valmistamiseksi FI105399B (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP1334292 1992-01-28
JP1334292 1992-01-28
JP6622192 1992-03-24
JP6622192 1992-03-24
JP32576092 1992-12-04
JP32576092 1992-12-04
JP9300103 1993-01-28
PCT/JP1993/000103 WO1993015057A1 (en) 1992-01-28 1993-01-28 Pyridinecarboximidamide compound and use thereof

Publications (3)

Publication Number Publication Date
FI943508A0 FI943508A0 (fi) 1994-07-26
FI943508A FI943508A (fi) 1994-09-22
FI105399B true FI105399B (fi) 2000-08-15

Family

ID=27280214

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943508A FI105399B (fi) 1992-01-28 1994-07-26 Menetelmä terapeuttisesti käyttökelpoisten N-syano-3-pyridiinikarboksiamidiinijohdannaisten valmistamiseksi

Country Status (18)

Country Link
US (1) US5508293A (xx)
EP (1) EP0634400B1 (xx)
JP (1) JP2648395B2 (xx)
KR (1) KR100249755B1 (xx)
CN (1) CN1043760C (xx)
AT (1) ATE151073T1 (xx)
AU (1) AU674839B2 (xx)
CA (1) CA2129013C (xx)
DE (1) DE69309454T2 (xx)
DK (1) DK0634400T3 (xx)
ES (1) ES2100522T3 (xx)
FI (1) FI105399B (xx)
HK (1) HK1000094A1 (xx)
HU (1) HU218487B (xx)
MX (1) MX9300433A (xx)
NO (1) NO302070B1 (xx)
TW (1) TW232009B (xx)
WO (1) WO1993015057A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin
WO1997000239A1 (fr) * 1995-06-14 1997-01-03 Sankyo Company, Limited Medicament contre l'angine contenant un derive nitroxy comme ingredient actif
WO1998035673A1 (fr) * 1997-02-14 1998-08-20 Kirin Beer Kabushiki Kaisha Medicaments utilises dans la decongestion du flux sanguin peripherique
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
JP2003321329A (ja) * 2002-04-25 2003-11-11 Kirin Brewery Co Ltd 育毛剤
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
JP2007525165A (ja) 2003-03-07 2007-09-06 トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク タイプ1ライアノジン受容体に基づく方法
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
TW200908984A (en) * 2007-08-07 2009-03-01 Piramal Life Sciences Ltd Pyridyl derivatives, their preparation and use
EP3088390A1 (en) 2015-04-30 2016-11-02 Bayer CropScience AG Catalytic hydrogenation of substituted cyanopyridines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662567B2 (ja) * 1988-12-27 1994-08-17 麒麟麦酒株式会社 ピリジンカルボキシイミダミド誘導体、その製造中間体、製造法および用途
FI95244C (fi) * 1988-12-27 1996-01-10 Kirin Brewery Analogiamenetelmä valmistaa lääkeaineina käyttökelpoisia uusia karboksimidiamidijohdannaisia tai niiden farmaseuttisesti sopivia happoadditiosuoloja
JP2846070B2 (ja) * 1989-11-29 1999-01-13 麒麟麦酒株式会社 カルボキシイミダミド誘導体

Also Published As

Publication number Publication date
NO302070B1 (no) 1998-01-19
CA2129013A1 (en) 1993-07-29
MX9300433A (es) 1994-07-29
CA2129013C (en) 2001-08-14
US5508293A (en) 1996-04-16
HU9402218D0 (en) 1994-09-28
WO1993015057A1 (en) 1993-08-05
FI943508A0 (fi) 1994-07-26
CN1043760C (zh) 1999-06-23
AU3367793A (en) 1993-09-01
EP0634400B1 (en) 1997-04-02
AU674839B2 (en) 1997-01-16
HU218487B (hu) 2000-09-28
KR100249755B1 (ko) 2000-04-01
NO942740L (no) 1994-09-27
TW232009B (xx) 1994-10-11
EP0634400A1 (en) 1995-01-18
KR950700255A (ko) 1995-01-16
FI943508A (fi) 1994-09-22
ES2100522T3 (es) 1997-06-16
JP2648395B2 (ja) 1997-08-27
ATE151073T1 (de) 1997-04-15
DK0634400T3 (da) 1997-04-28
DE69309454D1 (de) 1997-05-07
HUT70506A (en) 1995-10-30
DE69309454T2 (de) 1997-08-14
NO942740D0 (no) 1994-07-22
HK1000094A1 (en) 1997-11-21
EP0634400A4 (en) 1995-06-14
CN1077949A (zh) 1993-11-03

Similar Documents

Publication Publication Date Title
FI105399B (fi) Menetelmä terapeuttisesti käyttökelpoisten N-syano-3-pyridiinikarboksiamidiinijohdannaisten valmistamiseksi
FI82453C (fi) Foerfarande foer framstaellning av nya antibakteriella aminometyloxooxazolidinylbensenderivat.
FI102895B (fi) Menetelmä terapeuttisesti aktiivisten 5-(fenyylisulfonyyliamino)- ja 5 -(fenyylisulfonyyliaminokarbonyyli)pyridiini-2-karboksyylihappoamidien valmistamiseksi
SU1344246A3 (ru) Способ получени замещенных хиназолинонов-2
IE71155B1 (en) Acyl compounds
JP4408455B2 (ja) 細胞増殖抑制剤としてのシアノグアニジン
HU208811B (en) Process for producton of biaryl-compounds and pharmaceutical compositions comprising them as medical agent
US20150087842A1 (en) Process For The Preparation Of Benzimidazole Derivatives And Salts Thereof
US4148801A (en) 3-[(Chlorophenylsulfonyl)methyl]-1,2,4-oxadiazole-5-carboxylic acid derivatives
JP2002509930A (ja) ベンゾ複素環ジスタマイシン誘導体、その製造方法および抗腫瘍薬としてのそれの使用
JPH01186872A (ja) 3,6−ジヒドロ−1,5(2h)−ピリミジンカルボン酸エステル類
JPH06128230A (ja) 2−ホルミルピリジンチオセミカルバゾン抗腫瘍剤
CA3031621A1 (en) Production method for pyrazole-amide compound
US6646129B2 (en) Cyanoguanidines as cell proliferation inhibitors
HU204786B (en) Process for producing new dihydropyridine amide derivatives and pharmaceutical compositions comprising such compounds
JP2002521470A (ja) 硫化ジスタマイシン誘導体、それの製造方法、ならびにそれの抗腫瘍薬としての使用
JP2002521471A (ja) 酸化硫化ジスタマイシン誘導体、それの製造方法、ならびにそれの抗腫瘍薬としての使用
CZ276092A3 (en) Heterocyclically substituted quinolylmethoxy-phenyl acetamides
CZ280337B6 (cs) Estery kyseliny dusičné s deriváty cyklohexanolu
WO1992019611A1 (fr) Nouveaux derives de benzopyranne
JPH0515704B2 (xx)
EP0636621A1 (en) Beta-mercapto-propanamide derivatives useful in the treatment of cardiovascular diseases
KR20000032633A (ko) 신규의 피리미딘 유도체 및 그의 제조방법
JP2023538755A (ja) 硫黄含有置換基を有する2,2-ジフルオロ-1,3-ベンゾジオキソール誘導体の調製のための方法
JPH0597841A (ja) イソクマリン誘導体